Cargando…

Hepatocellular carcinoma reduces ATXN7L3 to evade estrogen-dependent growth suppression

Detalles Bibliográficos
Autores principales:	Bean, Joe, Mohan, Ryan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750566/ https://www.ncbi.nlm.nih.gov/pubmed/33340995 http://dx.doi.org/10.1016/j.ebiom.2020.103179

Ejemplares similares

ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function
por: Sun, Ning, et al.
Publicado: (2020)

Analysis of (CAG)(n) expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy
por: Zhou, X., et al.
Publicado: (2018)

Fatal Attraction Evaded: How Pathogenic Bacteria Resist Cationic Polypeptides
por: Ganz, Tomas
Publicado: (2001)

Mid-Gestation lethality of Atxn2l-Ablated Mice
por: Key, Jana, et al.
Publicado: (2020)

A model for the dynamics of expanded CAG repeat alleles: ATXN2 and ATXN3 as prototypes
por: Sena, Lucas Schenatto, et al.
Publicado: (2023)

Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 mice
por: Carrell, Ellie M., et al.
Publicado: (2022)

Co‐occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades
por: Wu, Chao, et al.
Publicado: (2019)

Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans
por: Nel, Melissa, et al.
Publicado: (2021)

Rad51C-ATXN7 fusion gene expression in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2016)

ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance
por: Lin, Li, et al.
Publicado: (2019)

Downregulation of circATXN7 represses non‐small cell lung cancer growth by releasing miR‐7‐5p
por: Li, Dongliang, et al.
Publicado: (2022)

The complex structure of ATXN2 genetic variation
por: Pulst, Stefan M.
Publicado: (2018)

ATXN2 a culprit with multiple facets
por: Nkiliza, Aurore, et al.
Publicado: (2017)

Novel ATXN1/ATXN1L::NUTM2A fusions identified in aggressive infant sarcomas with gene expression and methylation patterns similar to CIC-rearranged sarcoma
por: Xu, Feng, et al.
Publicado: (2022)

Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1
por: Coffin, Stephanie L., et al.
Publicado: (2023)

Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1
por: Coffin, Stephanie L., et al.
Publicado: (2023)

Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population
por: Faruq, Mohammed, et al.
Publicado: (2015)

TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L
por: Wong, Derek, et al.
Publicado: (2020)

Does Whistleblowing on Tax Evaders Reduce Ingroup Cooperation?
por: Chapkovski, Philipp, et al.
Publicado: (2021)

New alternative splicing variants of the ATXN2 transcript
por: Lastres-Becker, Isabel, et al.
Publicado: (2019)

Circular RNA ATXN7 is upregulated in non-small cell lung cancer and promotes disease progression
por: Huang, Qi, et al.
Publicado: (2019)

ATXN2 trinucleotide repeat length correlates with risk of ALS
por: Sproviero, William, et al.
Publicado: (2017)

Parkinson’s disease associated with pure ATXN10 repeat expansion
por: Schüle, Birgitt, et al.
Publicado: (2017)

ATXN3 promotes prostate cancer progression by stabilizing YAP
por: Wu, Longxiang, et al.
Publicado: (2023)

Estrogen as therapy for breast cancer
por: Ingle, James N
Publicado: (2002)

Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression
por: Gardiner, S L, et al.
Publicado: (2017)

MicroRNA-25/ATXN3 interaction regulates human colon cancer cell growth and migration
por: Li, Dingyun, et al.
Publicado: (2019)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
por: McDermott, Martina S.J., et al.
Publicado: (2017)

Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat
por: Scoles, Daniel R., et al.
Publicado: (2015)

Bringing estrogen receptors under control
por: Horwitz, Kathryn B
Publicado: (1999)

How does the estrogen receptor work?
por: Gross, Jennifer M, et al.
Publicado: (2002)

Fish populations surviving estrogen pollution
por: Wedekind, Claus
Publicado: (2014)

Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1
por: Coover, Robert A., et al.
Publicado: (2018)

UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
por: Bastian, Lorenz, et al.
Publicado: (2022)

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL
por: Passet, Marie, et al.
Publicado: (2022)

Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism
por: Casse, Fanny, et al.
Publicado: (2023)

ATXN3 controls DNA replication and transcription by regulating chromatin structure
por: Hernández‐Carralero, Esperanza, et al.
Publicado: (2023)

DUB-independent regulation of pVHL by OTUD6B suppresses hepatocellular carcinoma
por: Dai, Xiaoming, et al.
Publicado: (2020)

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
por: Song, Yeonhwa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b1rjcjtsn2n9g2fiuqvq67hvvb